Safety and efficacy of tirzepatide as an add-on to single oral antihyperglycaemic medication in patients with type 2 diabetes in Japan (SURPASS J-combo): a multicentre, randomised, open-label, parallel-group, phase 3 trial
用户eY45x3i-gSFQ
1个月前
77
10
已完结
1. 系统已在2026-06-17 13:53:39对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/s2213-8587(22)00187-5
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S2213858722001875
其他信息:
出版社: Elsevier BV
作者: Takashi Kadowaki; Rina Chin; Akichika Ozeki; Takeshi Imaoka; Yoshihiro Ogawa
